EditorialOpen Access · CC BY 4.0
Special Issue “Metformin: Mechanism and Application 2023”
Pharmaceuticals · 11.08.2026 · 19 (8) · 1263
DOI: 10.3390/ph19081263 ↗Kurz gefasst
Editorial in der Zeitschrift Pharmaceuticals, online erschienen am 11.08.2026. Verfasst von Agnieszka Śliwińska. Beteiligte Einrichtung: Department of Nucleic Acid Biochemistry, Medical University of Lodz, 92-213 Lodz, Poland. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Metformin remains the cornerstone of pharmacological therapy for type 2 diabetes mellitus (T2DM) [...]
Autor:innen und Institutionen
- Department of Nucleic Acid Biochemistry, Medical University of Lodz, 92-213 Lodz, Poland.
ORCID-Profile: Agnieszka Śliwińska
Zitieren
APA
Śliwińska, A. (2026). Special Issue “Metformin: Mechanism and Application 2023”. Pharmaceuticals, 19(8), 1263. https://doi.org/10.3390/ph19081263
Vancouver
Śliwińska A. Special Issue “Metformin: Mechanism and Application 2023”. Pharmaceuticals. 2026;19(8):1263. doi:10.3390/ph19081263
BibTeX
@article{liwiska2026,
author = {Śliwińska, Agnieszka},
title = {Special Issue “Metformin: Mechanism and Application 2023”},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {8},
pages = {1263},
doi = {10.3390/ph19081263}
}
EUVIMED